Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 31, 2026.

Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy

Piero Poletti, Marcello Tirani, Danilo Cereda and 14 more

JAMA Network Open · 2021

doi:10.1001/jamanetworkopen.2021.1085

Abstract

Question. What is the association of age with the likelihood of developing respiratory symptoms or fever greater than or equal to 37.5 °C and the association of age with the likelihood of progressing to critical disease after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection?

Findings. In this cohort study, 5484 quarantined case contacts were monitored daily for symptoms for at least 2 weeks and were tested for infection via real-time reverse transcriptase–polymerase chain reaction or serological screening more than 1 month after identification. Only 26.1% of infected individuals younger than 60 years developed respiratory symptoms or fever greater than or equal to 37.5 °C, but 6.6% of infected participants aged 60 years or older developed critical disease.

Meaning. The low proportion of children and young adults who developed symptoms highlights the possible challenges in readily identifying SARS-CoV-2 infections.

Importance. Solid estimates of the risk of developing symptoms and of progressing to critical disease in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are key to interpreting coronavirus disease 2019 (COVID-19) dynamics, identifying the settings and the segments of the population where transmission is more likely to remain undetected, and defining effective control strategies.

Objective. To estimate the association of age with the likelihood of developing symptoms and the association of age with the likelihood of progressing to critical illness after SARS-CoV-2 infection.

Design, Setting, and Participants. This cohort study analyzed quarantined case contacts, identified between February 20 and April 16, 2020, in the Lombardy region of Italy. Contacts were monitored daily for symptoms and tested for SARS-CoV-2 infection, by either real-time reverse transcriptase–polymerase chain reaction using nasopharyngeal swabs or retrospectively via IgG serological assays. Close contacts of individuals with laboratory-confirmed COVID-19 were selected as those belonging to clusters (ie, groups of contacts associated with an index case) where all individuals were followed up for symptoms and tested for SARS-CoV-2 infection. Data were analyzed from February to June 2020.

Exposure. Close contact with individuals with confirmed COVID-19 cases as identified by contact tracing operations.

Main Outcomes and Measures. Age-specific estimates of the risk of developing respiratory symptoms or fever greater than or equal to 37.5 °C and of experiencing critical disease (defined as requiring intensive care or resulting in death) in SARS-CoV-2–infected case contacts.

Results. In total, 5484 case contacts (median [interquartile range] age, 50 [30-61] years; 3086 female contacts [56.3%]) were analyzed, 2824 of whom (51.5%) tested positive for SARS-CoV-2 (median [interquartile range] age, 53 [34-64] years; 1604 female contacts [56.8%]). The proportion of infected persons who developed symptoms ranged from 18.1% (95% CI, 13.9%-22.9%) among participants younger than 20 years to 64.6% (95% CI, 56.6%-72.0%) for those aged 80 years or older. Most infected contacts (1948 of 2824 individuals [69.0%]) did not develop respiratory symptoms or fever greater than or equal to 37.5 °C. Only 26.1% (95% CI, 24.1%-28.2%) of infected individuals younger than 60 years developed respiratory symptoms or fever greater than or equal to 37.5 °C; among infected participants older than 60 years, 6.6% (95% CI, 5.1%-8.3%) developed critical disease. Female patients were 52.7% (95% CI, 24.4%-70.7%) less likely than male patients to develop critical disease after SARS-CoV-2 infection.

Conclusions and Relevance. In this Italian cohort study of close contacts of patients with confirmed SARS-CoV-2 infection, more than one-half of individuals tested positive for the virus. However, most infected individuals did not develop respiratory symptoms or fever. The low proportion of children and young adults who developed symptoms highlights the possible challenges in readily identifying SARS-CoV-2 infections.

References 28

  1. 1.
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis · 2020
    No notice
  2. 2.

    Byambasuren O, Cardona M, Bell K, Clark J, McLaws ML, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. J Assoc Med Microbiol Infect Dis Can. 2020;5(4):223-234

    Not in our library10.3138/jammi-2020-0030

  3. 3.

    Wang Y, He Y, Tong J,. Characterization of an asymptomatic cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals outside of Wuhan, China. Clin Infect Dis. 2020;71(16):2132-2138

    Not in our library10.1093/cid/ciaa629

  4. 4.

    Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020;173(5):362-367

    Not in our library10.7326/m20-3012

  5. 5.

    World Health Organization. Mask use in the context of COVID-19: interim guidance. Published June 5, 2020. Updated December 1, 2020. Accessed June 23, 2020. https://www.who.int/publications/i/item/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak

    Not in our library

  6. 6.

    World Health Organization. Coronavirus disease 2019 (COVID-19) weekly epidemiological update and weekly operational update. Published December 8, 2020. Accessed December 10, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

    Not in our library

  7. 7.

    Arons MM, Hatfield KM, Reddy SC,; Public Health–Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081-2090

    Not in our library10.1056/nejmoa2008457

  8. 8.
    A large COVID-19 outbreak in a high school 10 days after schools’ reopening, Israel, May 2020 · 2020
    No notice
  9. 9.
    SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp — Georgia, June 2020 · 2020
    No notice
  10. 10.
    Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China · 2021
    Corrected
  11. 11.

    He X, Lau EHY, Wu P,. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672-675

    Not in our library10.1038/s41591-020-0869-5

  12. 12.

    Wu JT, Leung K, Bushman M,. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26(4):506-510

    Not in our library10.1038/s41591-020-0822-7

  13. 13.

    Guzzetta G, Poletti P, Ajelli M,. Potential short-term outcome of an uncontrolled COVID-19 epidemic in Lombardy, Italy, February to March 2020. Euro Surveill. 2020;25(12):2000293

    Not in our library10.2807/1560-7917.es.2020.25.12.2000293

  14. 14.

    Poletti P, Tirani M, Cereda D,. Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020. Euro Surveill. 2020;25(31):2001383

    Not in our library10.2807/1560-7917.es.2020.25.31.2001383

  15. 15.

    Cereda D, Tirani M, Rovida F, The early phase of the COVID-19 outbreak in Lombardy, Italy. arXiv. Published March 23, 2020. Accessed February 8, 2021. https://arxiv.org/abs/2003.09320

    Not in our library

  16. 16.
    Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR · 2020
    Expression of concern
  17. 17.

    Cohen AN, Kessel B. False positives in reverse transcription PCR testing for SARS-CoV-2. medRxiv. Published May 20, 2020

    Not in our library10.1101/2020.04.26.20080911

  18. 18.

    World Health Organization. Contact tracing in the context of COVID-19: interim guidance, 10 May 2020. Published May 10, 2020. Accessed June 8, 2020. https://apps.who.int/iris/handle/10665/332049

    Not in our library

  19. 19.

    Lauer SA, Grantz KH, Bi Q,. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577-582

    Not in our library10.7326/m20-0504

  20. 20.
    Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively · 2020
    No notice
  21. 21.
    An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment · 2020
    No notice
  22. 22.

    Emery JC, Russell TW, Liu Y,. The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship. eLife. 2020;9:e58699

    Not in our library10.7554/elife.58699

  23. 23.

    Hellewell J, Abbott S, Gimma A,; Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488-e496

    Not in our library10.1016/s2214-109x(20)30074-7

  24. 24.

    Bi Q, Wu Y, Mei S,. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-919

    Not in our library10.1016/s1473-3099(20)30287-5

  25. 25.

    Lavezzo E, Franchin E, Ciavarella C,; Imperial College COVID-19 Response Team; Imperial College COVID-19 Response Team. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature. 2020;584(7821):425-429

    Not in our library10.1038/s41586-020-2488-1

  26. 26.
    Estimates of the severity of coronavirus disease 2019: a model-based analysis · 2020
    Corrected
  27. 27.

    Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020;173(4):262-267

    Not in our library10.7326/m20-1495

  28. 28.

    Long QX, Tang XJ, Shi QL,. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26(8):1200-1204

    Not in our library10.1038/s41591-020-0965-6

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.